ArticleBrain and behavior2026
Decreased Myocardial 123I-MIBG Uptake Without Sympathetic Denervation: An Autopsy Report of Autoimmune Autonomic Ganglionopathy.
Article in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAutoimmune autonomic ganglionopathy (AAG) is a rare disorder characterized by widespread autonomic failure due to antibodies targeting the ganglionic nicotinic acetylcholine receptor (gAChR). Although the clinical manifestations of AAG have been widely reported, autopsy findings in human cases remain undocumented.
methodsWe examined the clinical course, imaging data, and autopsy findings of a patient with AAG who survived for 14 years. Clinical symptoms, cardiac MIBG scintigraphy results, treatment response, and histological features of sympathetic ganglia and cardiac nerve fibers were analyzed.
resultsThe patient initially showed markedly reduced MIBG cardiac uptake, which improved with intravenous immunoglobulin therapy. After a prolonged clinical course with recurrent infections and nutritional decline, he died at age 78. Autopsy revealed preserved thoracic sympathetic ganglia and intact postganglionic sympathetic fibers in the heart. Mild perivascular lymphocytic infiltration was observed, but no neuronophagia or dense inflammatory infiltrates. Phosphorylated α-synuclein was absent in the central and peripheral nervous systems. The enteric plexus was preserved, without overt neuronal loss. Age-associated tau pathology was confined to the entorhinal cortex.
conclusionDespite functional sympathetic impairment evident in reduced MIBG uptake and severe gastrointestinal dysmotility, there was no histologic evidence of sympathetic nerve degeneration or neuronal loss in the enteric plexus, supporting a postsynaptic channelopathy mechanism in AAG. The mild inflammation observed may reflect systemic illness rather than primary autoimmune pathology. This is the first report correlating longitudinal clinical data, imaging, and postmortem pathology in AAG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.